Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT

Completed

Conditions studied: Smoking, Tobacco Use Disorder

In brief

Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant women are less likely to disclose their smoking status to doctors or study researchers. This study will evaluate the use of a new biomarker of nicotine metabolism to estimate tobacco use in a group of pregnant women who participated in the New England Smoking Cessation and Reduction in Pregnancy Trial (SCRIPT).

Key facts

Study ID
NCT00519766
Run by
Memorial Hospital of Rhode Island
People needed
252
Starts
1997-09-01
Expected to finish
2002-11-01
Last updated by the study team
2014-05-23

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.